Jun-Eui Park

Title: Innovations of Jun-Eui Park in Autoimmune Disease Treatment.

Introduction

Jun-Eui Park is a notable inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of immunology, particularly in the treatment of autoimmune diseases. His innovative approach focuses on enhancing the therapeutic efficacy of dendritic cells.

Latest Patents

Jun-Eui Park holds a patent for a method that prepares dendritic cells with increased specific gene expression. The patent is titled "Method for preparing dendritic cells with increased specific gene expression, and composition for treating or preventing autoimmune diseases, containing dendritic cells prepared using same." This invention relates to generating semi-mature dendritic cells by treating immature dendritic cells with auto-antigens, cytokines, and PGE2. The method aims to treat autoimmune diseases, especially rheumatoid arthritis, by increasing the levels of NR4A2 and/or UBASH3B at gene or protein levels more than two-fold compared to immature dendritic cells. The invention also includes a cell therapeutic agent for treating or preventing autoimmune diseases, which contains the semi-mature dendritic cells as an active ingredient.

Career Highlights

Jun-Eui Park is associated with Jw Creagene Inc., where he continues to advance his research and innovations. His work has the potential to significantly impact the treatment landscape for autoimmune diseases.

Collaborations

He collaborates with notable colleagues, including Yong-Soo Bae and Yun-Ju Woo, who contribute to his research endeavors.

Conclusion

Jun-Eui Park's innovative methods in preparing dendritic cells represent a promising advancement in the treatment of autoimmune diseases. His contributions are paving the way for more effective therapies in the field of immunology.